APA (7th ed.) Citation

Armstrong, E. J., Chen, D. C., Singh, G. D., Amsterdam, E. A., & Laird, J. R. (2015). Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Vascular medicine (London, England), 20(3), 237-244. https://doi.org/10.1177/1358863X15574321

Chicago Style (17th ed.) Citation

Armstrong, Ehrin J., Debbie C. Chen, Gagan D. Singh, Ezra A. Amsterdam, and John R. Laird. "Angiotensin-converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Is Associated with Reduced Major Adverse Cardiovascular Events Among Patients with Critical Limb Ischemia." Vascular Medicine (London, England) 20, no. 3 (2015): 237-244. https://doi.org/10.1177/1358863X15574321.

MLA (9th ed.) Citation

Armstrong, Ehrin J., et al. "Angiotensin-converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Is Associated with Reduced Major Adverse Cardiovascular Events Among Patients with Critical Limb Ischemia." Vascular Medicine (London, England), vol. 20, no. 3, 2015, pp. 237-244, https://doi.org/10.1177/1358863X15574321.